US Stock MarketDetailed Quotes
MRKR Marker Therapeutics
- 4.9100
- +1.0200+26.22%
Trading Dec 12 15:45 ET
43.81MMarket Cap-4.50P/E (TTM)
5.7616High3.8500Low413.75KVolume3.8500Open3.8900Pre Close2.04MTurnover6.12%Turnover RatioLossP/E (Static)8.92MShares6.156852wk High5.88P/B33.21MFloat Cap2.437752wk Low--Dividend TTM6.76MShs Float2447.9980Historical High--Div YieldTTM49.14%Amplitude0.6700Historical Low4.9280Avg Price1Lot Size
About Marker Therapeutics Company
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
Company Profile
SymbolMRKR
Company NameMarker Therapeutics
Listing DateNov 7, 2016
Founded1991
CEODr. Juan Vera, M.D.
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address2450 Holcombe Boulevard,Suite BCM-A, MS: BCM251
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77021
Phone1-713-400-6400
Company Executives
- Name
- Position
- Salary
- Dr. Juan Vera, M.D.
- Director, President, Chief Executive Officer, Principal Financial Officer and Principal Accounting Officer
- 585.25K
- N. David Eansor
- Chairman of the Board
- 124.04K
- John Wilson
- Independent Director
- 63.44K
- Dr. Katharine Knobil, M.D.
- Independent Director
- 79.67K
- Steven A. Elms
- Independent Director
- 76.14K
Heat List
US
Overall
Symbol
Price
% Chg
No Data